The weekly litigation news digest is live. Subscribe now

IP Verse

Ophthalmological Composition - EP3426226

The patent EP3426226 was granted to Ursapharm Arzneimittel on May 4, 2022. The application was filed on Mar 7, 2017 under application number EP17709641A. The patent is currently recorded with a legal status of "Revoked".

EP3426226

URSAPHARM ARZNEIMITTEL
Application Number
EP17709641A
Filing Date
Mar 7, 2017
Status
Revoked
Aug 30, 2024
Publication Date
May 4, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
BITOPFeb 3, 2023HEIDEADMISSIBLE
BAUSCH LOMB IRELANDFeb 2, 2023MAIWALDADMISSIBLE
PHARMA STULLNJun 9, 2022GREINERADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONDE102014007423
DESCRIPTIONEP0671161
DESCRIPTIONEP2214658
INTERNATIONAL-SEARCH-REPORTDE102014007423
INTERNATIONAL-SEARCH-REPORTUS2005089500
INTERNATIONAL-SEARCH-REPORTWO03049747
INTERNATIONAL-SEARCH-REPORTWO03053452
OPPOSITIONDE102014007423
OPPOSITIONDE102016203696
OPPOSITIONUS2005043271
OPPOSITIONUS2005089500
OPPOSITIONWO03049747
OPPOSITIONWO03053452
OPPOSITIONWO2015177353
OPPOSITIONWO2017153415

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents